Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact eventeducation@endocrine.org.
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
Showing session: reset
SGLT-2 Inhibitors: What is the Role of this New Class of Drugs in Diabetes Management?
| Browse by: | Sort by: |
Welcome & Introduction
Mark E Molitch, MD
Northwestern Univ Feinberg School of Medicine, Chicago, IL
Free
Slides + audio
The Role of the Kidney in Glucose Homeostasis and as New Target in Diabetes Management
John E Gerich, MD
University of Rochester Medical Center, Wayne, PA
Free
Slides + audio
Update on SGLT-2 Inhibitor Clinical Trials: Safety and Efficacy
Vivian A Fonseca, MD
Tulane University Health Science, New Orleans, LA
Free
Slides + audio
Challenges in the Practical Application of SGLT-2 Inhibitor Therapy
Jaime A Davidson, MD, FACP, MACE
University of Texas Southwestern Medical Center, Dallas, TX
Free
Slides + audio
Panel Discussion
Free
Slides + audio
